Condition

ALL, Recurrent, Adult (2)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Goethe University (2)

Collaborator

University Hospital Schleswig-Holstein (1)

Intervention

blinatumomab (2)

venetoclax (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

all, recurrent, adult

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting

ALL, Recurrent, Adult

Blinatumomab

Frankfurt (Main), Hessen, Germany
+21 more

Mar 16, 2022

ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

Recruiting

ALL, Recurrent, Adult

Frankfurt (Main), Hessen, Germany
+1 more

Jan 6, 2022